Prospective Evaluation of the Frequency and Severity of Symptoms in Lyme Disease Patients With Erythema Migrans Compared With Matched Controls at Baseline, 6 Months, and 12 Months
Authors:
- 23 January 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 71 (12) , 3118-3124
Abstract
Erythema migrans is the most common clinical manifestation of Lyme disease. Despite antibiotic therapy, typically at least 10% of adult patients with erythema migrans experience persistence of at least 1 subjective symptom for ≥6 months (posttreatment Lyme disease symptoms [PTLDS]). This study was designed to determine whether the frequency and severity (based on a visual analogue scale) of 12 particular symptoms in patients with erythema migrans (n = 52) differed from matched control subjects (n = 104) followed prospectively for 12 months. At baseline, patients with Lyme disease were more likely than controls to have at least 1 symptom (P = .006). Among symptomatic subjects, Lyme disease patients had a higher mean number of symptoms (P < .001) and a higher mean total symptom severity score (P < .001). At both 6 and 12 months, however, there were no significant differences for these variables and no significant differences in the frequency or severity of any of the 12 individual symptoms assessed. However, 10 patients were clinically assessed as having possible PTLDS. Patients with erythema migrans were more likely than matched control subjects to be symptomatic at baseline with a greater symptom severity score, but this was not found at ≥6 months. Use of symptom survey data alone, however, was less likely to identify patients with possible PTLDS compared with individual clinical assessments. Because it is very challenging to be certain that the presence of long-term symptoms in a particular patient is correctly attributable to having had Lyme disease, an objective biomarker would be highly desirable.Keywords
Funding Information
- National Center for Advancing Translational Sciences
This publication has 14 references indexed in Scilit:
- Co-infections in Persons with Early Lyme Disease, New York, USAEmerging Infectious Diseases, 2019
- Evaluation of Prospectively Followed Adult Patients with Erythema Migrans Using the Beck Depression Inventory Second EditionThe American Journal of Medicine, 2019
- Fatigue in patients with erythema migransDiagnostic Microbiology and Infectious Disease, 2016
- Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme DiseaseNew England Journal of Medicine, 2016
- Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme DiseaseClinical Infectious Diseases, 2015
- Long-term Assessment of Health-Related Quality of Life in Patients With Culture-Confirmed Early Lyme DiseaseClinical Infectious Diseases, 2015
- Does This Patient Have Erythema Migrans?JAMA, 2007
- The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2006
- Long-term follow-up of patients with culture-confirmed lyme diseaseThe American Journal of Medicine, 2003
- Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme DiseaseNew England Journal of Medicine, 2001